|
Date
|
Research Title
|
Institution
|
|
March 2007
|
|
|
| Harry W. Schroeder, Jr., MD, Ph.D. |
HLA*B44 and memory B cells in patients with sino-pulmonary infections
|
University of Alabama at Birmingham |
|
November 2006
|
|
|
| Jennifer M. Puck, MD |
T Cell Receptor Excision Circles (TRECs): a Newborn
Screening Tool for SCID |
University of California, San Francisco |
| Marie Jose Stasia, Ph.D. |
X+CGD and Nox2 superoxidase mutants powerful tools to
study NADPH oxidase activation |
Universite Joseph Fourier |
| Troy R. Torgerson, MD |
A Cell Instrinic Role for FOXP3 in the Human Immune
System |
Children's Hospital & Regional Medical Center |
|
July 2006
|
|
|
| Eyal Grunebaum, MD |
Correcting PNP Deficiencies by intracellular delivery
of PNP fused to PTD |
Hospital for Sick Children |
| Peter E. Newburger, MD |
Novel approach to oral gene therapy for CGD |
University of Massachusetts Medical School |
|
March 2006
|
|
|
| Peter K. Gregersen, MD |
Whole genome association studies in CVID and IGAD
|
North Shore LIJ Health System
|
| Lisa Borghesi, Ph.D. |
Regulation of E47 activity and V(D)J recombination in
mouse and man |
University of Pittsburgh |
| Brian R. Davis, Ph.D. |
Nuclease facilitated gene editing for PIDD |
Institute for Inherited Disease Research |
| Michael B. Jordan, MD |
Immune regulation in hemophagocytic
lymphohistiocytosis |
Cincinnati Children's Hospital |
|
November 2005
|
|
|
| Anna M. Blom, MSc, Ph.D. |
Deficiencies of complement inhibitors |
Lund University |
| Scott B. Snapper, MD, Ph.D. |
Targeting C-linked neutropenia:Strategies to
investigate an activated WASP |
Massachusetts General Hospital |
|
July 2005
|
|
|
| David T. Teachey, MD |
Improving treatment of the autoimmune lymphoproliferative syndrome |
Children's Hospital of Philadelphia |
|
March 2005
|
|
|
| Bodo Grimbacher, MD |
Genetics of antibody deficiency syndrome |
University College London |
| Emanuela Castigli, Ph.D. |
IgAD and CVID:role of APRIL/BAFF-TACI and BAFF-R axes |
Children's Hospital Boston |
| Douglas McDonald, MD, Ph.D. |
Novel immunodeficiency involving toll-like receptor7,8,9 defects |
Children's Hospital Boston |
| Janos Sumegi, MD, Ph.D. |
The binding repertoire of the Duncan Disease (XLP) gene product SAP |
Cincinnati Children's Hospital |
|
November 2004
|
|
|
| Carol Miao, Ph.D. |
Gene therapy for Wiskott-Aldrich Syndrome |
Children's Hospital and Regional
Medical Center |
| Yatin Vyas, MD |
Role of Human WASp in lymphocyte signaling |
Children's Hospital of Pittsburgh |
|
July 2004
|
|
|
| Anthony Infante, MD, Ph.D. |
Thymus in mouse model of DiGeorge Syndrome |
Univ. of Texas Health Science |
| Jordan Orange, MD, Ph.D. |
Human NEMO mutation and immunodeficiency |
Children's Hospital of Philadelphia |
| Carol Webb, Ph.D. |
Role for human bright in XLA |
Oklahoma Medical Research
Foundation |
|
March 2004
|
|
|
| Ramsay Fuleihan, MD |
Toward gene therapy of X-linked hyper IgM |
Yale University School of
Medicine |
| Donald Kohn, MD |
A site specific gene therapy method to ameliorate PIDD |
Children's Hospital Los Angeles |
| Narayanaswamy Ramesh, Ph.D. |
Role of WIP in WASP homeostasis |
Children's Hospital Boston |
|
January 2004
|
|
|
|
Andrew Scharenberg, MD
|
Signaling competent transformed cell lines for
functional analysis |
University of Washington |
Charlotte
Cunningham-Rundles, MD, Ph.D. |
Investigation of ICOS and other signaling pathways in CVID |
Mt. Sinai School of Medicine |
| Kim Nichols, MD |
SRC Homology 2 (SH2) domain containing gene 1A (SH2D1A) |
Children's Hospital of Philadelphia |
